12/07/2025
Psychiatry | ADHD and Autism
Incepta Pharmaceuticals Ltd is the forerunner of today’s pharmaceutical industry and one of the leading pharmaceutical companies of Bangladesh.
Dhaka
Monday | 08:30 - 17:30 |
Tuesday | 08:30 - 17:30 |
Wednesday | 08:30 - 17:30 |
Thursday | 08:30 - 13:30 |
Saturday | 08:30 - 17:30 |
Sunday | 08:30 - 17:30 |
Be the first to know and let us send you an email when Incepta Pharmaceuticals Ltd posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Send a message to Incepta Pharmaceuticals Ltd:
Founded in 1999, Incepta Pharmaceuticals Ltd is the forerunner of today’s pharmaceutical industry and one of the leading pharmaceutical companies of Bangladesh. The company has a very large diversified manufacturing facility at Savar, located 35 km away from the center of the capital city of Dhaka. Incepta’s success came from the company’s state-of-the-art manufacturing facility, adherence to modern technology and production of innovative products that made Incepta a unique company in South-East Asia.
Along with the receival of UK-MHRA cGMP certificate, Incepta has established another state-of-the art manufacturing facility at Dhamrai with a target to get the US FDA accreditation. We are committed to become a global leader in health care and change millions of lives through providing access to safe, effective and affordable medicines and related health care services to the people who need them. Incepta is currently manufacturing a range of bio-tech products including
Human Insulin, Erythropoietin, Filgrastim, Vaccine etc. along with regular chemical molecules.
Incepta is managed and lead by a dedicated and highly qualified team of professionals. As a company, we strive to maintain high ethical standards and a culture that value honesty, integrity and transparency in all levels. Guided by its brand statement, “Innovative Concept into Practice”, Incepta develops, manufactures and markets medicine to address the unmet medical needs of doctors’ community.